CK1δ and CK1ε Signaling Sustains Mitochondrial Metabolism and Cell Survival in Multiple MyelomaCANCER RESEARCHIF16.62023-09-131OAAI
Novel autophagy inhibitory strategies to overcome chemotherapy resistance in multiple myelomaCANCER RESEARCHIF16.62023-04-040PRE
A novel gene regulatory network model identifies master regulators in cancerCANCER RESEARCHIF16.62023-04-040PRE
Racial and ethnic differences in clonal hematopoiesis, tumor markers, and outcomes of patients with multiple myelomaBLOOD ADVANCESIF7.12022-06-2418OAAI
Plasma cell dependence on histone/protein deacetylase11 reveals a therapeutic target in multiple myelomaJCI INSIGHTIF6.12021-12-229OA
IAP and HDAC inhibitors interact synergistically in myeloma cells through noncanonical NF-κB- and caspase-8-dependent mechanismsBLOOD ADVANCESIF7.12021-10-0112OA
Metabolic Changes Are Associated with Melphalan Resistance in Multiple MyelomaJOURNAL OF PROTEOME RESEARCHIF3.62021-05-2013PREAI